• Oxaliplatin Resistance and PARP Inhibition in Gastric Cancer

  2026-08-31

  This reference study links Oxaliplatin resistance in gastric cancer to PARP1 activity and identifies compromised CDK1 activity as a potential vulnerability in BRCA-proficient tumors. Across patient-derived organoids, resistant cell models, and xenografts, the findings support combining Oxaliplatin with olaparib as a preclinical strategy for overcoming treatment resistance.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-31

  A 2025 study shows that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1 in peptide-dependent patterns. Its structure–activity analysis identifies peptide truncation and modification at tyrosine 4 as important determinants, while also highlighting the need to distinguish receptor-binding effects from demonstrated viral infection.

• FLAG tag Peptide: Exosome Assay Workflows

  2026-08-30

  Use the FLAG tag Peptide (DYKDDDDK) to build gentle, traceable purification and detection workflows for recombinant proteins, including mechanistic studies of exosome biology. Its peptide-based competition strategy helps preserve protein complexes while exposing limitations such as poor elution of 3X FLAG constructs.

• Clozapine as a Translational Map of Brain-Safety Biology

  2026-08-29

  Clozapine offers translational researchers more than a benchmark atypical antipsychotic medication: it connects polypharmacology, prefrontal ERK1/2 signaling activation, EGF receptor mediated signaling, behavioral models, and safety-oriented hepatotoxicity studies. This article presents a hypothesis-driven framework for using Clozapine to relate receptor engagement to circuit biology while keeping magnetic stimulation findings, pharmacology, and liver-risk data analytically distinct.

• WAY-100635 for 5-HT1A Mechanism Studies

  2026-08-28

  WAY-100635 is a high-affinity, silent 5-HT1A antagonist for separating receptor-mediated effects from broader serotonergic, cannabinoid, and behavioral signals. This workflow connects radioligand binding and functional assays with pain, affective-behavior, and imaging applications while emphasizing solvent control, assay validation, and interpretation limits.

• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-08-28

  Protect intact cellular and tissue proteins during OXPHOS, Western blot, Co-IP, and kinase workflows with an EDTA-free, broad-spectrum inhibitor format. This practical guide connects sample-preservation choices to the LRPPRC–dasatinib dual-genome OXPHOS study and provides executable starting conditions for extraction and troubleshooting.

• PP 2 (AG 1879): Mapping Src to Cell Fate

  2026-08-27

  A translational framework for using PP 2 (AG 1879) to interrogate Src-FAK-RhoA/ROCK signaling, connect cytoskeletal biology with cancer and immunology, and design more defensible cell-based studies.

• From Cy5 Probes to Translational RNA Insight

  2026-08-27

  How tunable Cy5-UTP incorporation can strengthen RNA detection workflows and help translational teams interpret advances in targeted mRNA delivery.

• Oridonin Protects Bone Through MAPK/NF-κB and BMP-2/RUNX2

  2026-08-26

  The reference study identifies oridonin as a dual-action candidate that suppresses thioacetamide-induced osteoclastogenesis while restoring osteogenic differentiation. Its central contribution is linking MAPK/NF-κB inhibition in osteoclast precursors with BMP-2/RUNX2 activation and reduced adipogenic bias in bone mesenchymal stem cells.

• Glycine, Ferritin, and Ferroptosis in Lens Cells

  2026-08-26

  The reference study identifies excessive lysosome-dependent ferritin degradation as a central cause of iron imbalance in ultraviolet B-stressed lens epithelial cells. Its findings suggest that glycine protects these cells through coordinated effects on lysosomal PAT1, Nrf2–NCOA4 signaling, and PCBP2-mediated iron transport rather than through nonspecific antioxidant activity alone.

• Oligo (dT) 25 Beads for mRNA Multiomics

  2026-08-25

  Oligo (dT) 25 Beads provide a practical route from complex animal or plant samples to polyadenylated mRNA for cDNA, RT-PCR, and RNA-seq workflows. Their magnetic format is especially useful for multiomics studies that require consistent transcript recovery across breeds, sexes, tissues, or experimental batches.

• Covalent HPV-16 E6 Inhibitors Restore p53

  2026-08-25

  The reference study identifies a genotype-defined vulnerability in HPV-16 E6 and shows that covalent, irreversible inhibition can restore p53 activity, trigger apoptosis or senescence, and suppress established HPV-driven tumors in vivo. Its combination of structural targeting, CRISPR on-target validation, transcriptomics, and xenograft testing provides a rigorous framework for evaluating viral oncoprotein inhibitors.

• YM-155 Hydrochloride: Assay Design for Survivin

  2026-08-24

  YM-155 hydrochloride is a selective survivin inhibitor for dissecting growth arrest, cell death, and treatment response. This guide translates Schwartz’s viability framework into practical assay decisions for apoptosis inhibitor research and translational cancer models.

• Itraconazole in Candida Biofilm Research

  2026-08-24

  Itraconazole combines triazole antifungal activity with CYP3A4, hedgehog, and angiogenesis-related research utility. This guide translates the PP2A–autophagy findings in Candida albicans biofilms into practical assay design, controls, and troubleshooting steps.

• PPM-18 for iNOS and NF-κB Research

  2026-08-23

  PPM-18 enables mechanism-focused studies of inflammatory nitric oxide signaling by suppressing NF-κB-dependent iNOS expression rather than directly blocking NOS catalysis. This guide connects macrophage, sepsis, and exploratory cardiovascular workflows with practical dosing, formulation, readout, and troubleshooting strategies.

8654 records 6/577 page Previous Next First page 上5页 678910 下5页 Last page